Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; no visible changes to page content.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision history updated from v3.4.0 to v3.4.1. No study details or other content were modified.SummaryDifference0.0%

- Check36 days agoChange DetectedThe label in the Study Record Dates changes from 'Last Update Posted (Estimated)' to 'Last Update Posted', a UI simplification that does not affect data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no substantive changes to the study details or page content were observed.SummaryDifference0.0%

- Check66 days agoChange Detected- Consolidated site locations under a single 'Locations' header listing California, Maryland, New Jersey, and Ohio, removing the separate state-specific location subsections.SummaryDifference0.4%

- Check95 days agoChange DetectedPublications section now notes that items are automatically filled from PubMed, and the revision tag has been updated to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.